Current Status of β-Blocking Drugs in the Treatment of Anxiety Disorders

Drugs

Volumn 36, Issue 6, 1988, Pages 773-783

  Tyrer, Peter ^a,b  

^a Mapperley Hospital   (United Kingdom)

^b ST CHARLES HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOCTAMINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHLORDIAZEPOXIDE; DIAZEPAM; OXPRENOLOL; PRACTOLOL; PROPRANOLOL; SOTALOL;

ANXIETY; DRUG EFFICACY; DRUG INDICATION; DRUG THERAPY; HEART PALPITATION; HUMAN; MAJOR CLINICAL STUDY; PANIC; PHOBIA; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REVIEW; STRESS; TREMOR;

ADRENERGIC BETA-ANTAGONISTS; ANXIETY DISORDERS; HUMAN;

EID: 0024246797     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/00003495-198836060-00006     Document Type: Review

References (64)

1. D-Propranolol and anxiety
2. Beta-adrenergic-receptor blockade with practolol in treatment of anxiety
3. Effect of beta blockade and beta stimulation on stage fright
4. Beneficial effect of beta-adrenergic blocking agents on ‘exam nerves’
5. A placebo controlled trial of diazepam and oxprenolol for anxiety
6. Verbal anxiety and the beta-adrenergic receptors: a facilitating mechanism?
7. The beta-adrenergic receptor blockade modification of the systemic haemodynamic effects of link trainer simulated flight
8. The treatment of social phobia: real-life rehearsal with nonprofessional therapists
9. Hyperdynamic beta-adrenergic circulatory state
10. Drug treatment of social phobias
11. Treatment of social phobia with atenolol
12. Peripheral versus central mechanisms accounting for anti-anxiety effect of propranolol
13. The effect of propranolol on anxiety
14. The influence of propranolol on the exposure in vivo of agoraphobics
15. Diazepam, propranolol and their combination in the management of chronic anxiety
16. The effect of beta adrenergic blocking drugs on speakers’ performance and memory
17. Plasma cate-cholamines and the effects of adrenergic beta-receptor blockade on cardiovascular reactions and subjective feelings during emotional stress
18. Drug inhibition of catecholamine-induced metabolic effects in humans
19. Practical aspects of the use of beta-blockers in anxiety states: situational anxiety
20. Effect of pindolol on stress-related disturbances of musical performances: preliminary communication
21. Effect of oxprenolol on stage-fright in musicians
22. Beneficial effects of nadolol on anxiety induced disturbance of performance in musicians: a comparison with diazepam and placebo
23. Beta-adrenoceptor antagonists in essential tremor
24. Controlled evaluation of the beta-adrenoreceptor blocking drug oxprenolol in anxiety
25. Clinical effects of beta-adrenergic blockers in psychiatry (propranolol, trimepranol)
26. Propranolol in chronic anxiety disorders: a controlled study
27. Short-term anti-anxiety effects of propranolol HC1
28. Propranolol and clonidine in the treatment of post-traumatic stress disorders of war
29. Oxprenolol in the treatment of examination nerves
30. Beta-blocking agents in the treatment of catecholamine-induced symptoms in musicians
31. The effect of propranolol on airway resistance
32. Agoraphobia, panic disorder and related conditions in the DSM-III-B and ICD-10
33. Peripheral beta-adrenergic receptors concerned with tremor
34. Oxprenolol in the treatment of anxiety due to environmental stress
35. Imipramine versus propranolol for the treatment of panic attacks: a pilot study
36. Stage fright in musicians: a model illustrating the effect of beta-blockers
37. Effect of a new adrenergic beta-blocking agent, H 56-28, on nervous heat complaints
38. Diazepam and propranolol in panic disorder and agoraphobia
39. Antianxiety effects of propranolol: a review of clinical studies
40. Benzodiazepine dependence — a review of the evidence
41. Beta-adrenergic blockade in the treatment of anxiety
42. Treatment outlines for the management of anxiety states
43. Propranolol in neurotic and thyrotoxic anxiety
44. Long-term benzodiazepine therapy: benefits and risks
45. Relationship between life events and personality in psychiatric disorder
46. Treatment of panic attacks with alprazolam and propranolol
47. Some new approaches to the treatment of anxiety
48. Propranolol in the treatment of anxiety neurosis
49. The comparison of panic disorder and agoraphobia with panic attacks
50. The use of beta-blocking drugs in psychiatry and neurology
51. The concept of somatic anxiety
52. Classification of anxiety disorders: a critique of DSM-III
53. Dependence as a limiting factor in the clinical use of minor tranquillisers
54. Personality disorder and mental illness
55. Effects of beta-adrenergic blockade with sotalol in chronic anxiety
56. Response to propranolol and diazepam in somatic and psychic anxiety
57. Physiological responses to propranolol and diazepam in chronic anxiety
58. Gradual withdrawal of diazepam after long-term therapy
59. Benzodiazepine withdrawal symptoms and propranolol
60. Comparative effects of propranolol and chlordiazepoxide in anxiety states